首页> 外文期刊>Molecular Metabolism >Nor-1, a novel incretin-responsive regulator of insulin genes and insulin secretion
【24h】

Nor-1, a novel incretin-responsive regulator of insulin genes and insulin secretion

机译:Nor-1,胰岛素基因和胰岛素分泌的新型肠促胰岛素反应调节剂

获取原文
           

摘要

B-cell failure at the onset of type 2 diabetes is caused by a decline in @b-cell function in the postprandial state and loss of pancreatic @b-cell mass. Recently, we showed an association between increased insulin secretion and a single nucleotide polymorphism (SNP), SNP rs12686676, in the NR4A3 gene locus encoding the nuclear receptor Nor-1. Nor-1 is expressed in @b-cells, however, not much is known about its function with regard to insulin gene expression and insulin secretion. Nor-1 is induced in a glucose-/incretin-dependent manner via the PKA pathway and directly induces insulin gene expression. Additionally, it stimulates insulin secretion possibly via regulation of potentially important genes in insulin exocytosis. Moreover, we show that the minor allele of NR4A3 SNP rs12686676 fully rescues incretin resistance provoked by a well-described polymorphism in TCF7L2. Thus, Nor-1 represents a promising new target for pharmacological intervention to fight diabetes.
机译:在2型糖尿病发作时B细胞衰竭是由餐后状态下@b细胞功能的下降和胰腺@b细胞质量的损失引起的。最近,我们在编码核受体Nor-1的NR4A3基因位点中显示出胰岛素分泌增加与单核苷酸多态性(SNP)SNP rs12686676之间的关联。 Nor-1在@b细胞中表达,但是,关于其在胰岛素基因表达和胰岛素分泌方面的功能知之甚少。 Nor-1通过PKA途径以葡萄糖/肠降血糖素依赖性方式被诱导,并直接诱导胰岛素基因表达。另外,它可能通过调节胰岛素胞吐作用中潜在重要基因来刺激胰岛素分泌。此外,我们显示,NR4A3 SNP rs12686676的次要等位基因完全拯救了由TCF7L2中一个众所周知的多态性引起的肠降血糖素抵抗。因此,Nor-1代表了抗糖尿病药理干预的新靶标。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号